Medical News

RSS

Intelligent algorithms for programming deep brain stimulation in Parkinson’s to be developed by Great Lakes NeuroTechnologies

Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.

22 Jan 2013

Chronic heart failure treatment, Inspra (eplerenone), accepted for use within NHS Wales

Inspra (eplerenone) has now been accepted by the All Wales Medicines Strategy Group (AWMSG) for use in adult patients with chronic heart failure (CHF) NYHA class II, in combination with standard optimal therapy...

22 Jan 2013

PathCentral announces roll-out of new pathology network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, and China-based Kindstar Globalgene Technology, Inc., today announced the roll-out of the PathCentral Pathology Network, an online professional pathology network that will enable Kindstar to access US pathologists and facilitate pathology consultations for more than 3,300 hospitals throughout China.

22 Jan 2013

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Using medical marijuana to treat conditions such as anxiety and depression is dangerous and has no basis in medical science, says Dr. Timothy R. Jennings, a prominent Tennessee psychiatrist and consultant to The Center for Counseling and Health Resources in Edmonds, WA.

22 Jan 2013

Calmangafodipir protects against side effects of cancer treatments

A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour.

22 Jan 2013

New special issue explores link between evolution and the body's fight against cancer

Over 500 billion cells in our bodies will be replaced daily, yet natural selection has enabled us to develop defenses against the cellular mutations which could cause cancer. It is this relationship between evolution and the body's fight against cancer which is explored in a new special issue of the Open Access journal Evolutionary Applications.

22 Jan 2013

Dutasteride decreases risk of biopsy detectable prostate cancer by 22.8%

The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.

22 Jan 2013

Simcere enters share transfer agreement with Devont Asset Management

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.

22 Jan 2013

Russia approves FzioMed’s Oxiplex gel for lumbar spine surgery

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the approval of Oxiplex in Russia. Oxiplex is an absorbable, clear, viscoelastic gel that is applied during lumbar spine surgery immediately prior to wound closure.

22 Jan 2013

Suppression of immune system function can occur in influenza patients

Investigators from 15 children's medical centers, including Nationwide Children's Hospital, observed and evaluated critically ill children with influenza to evaluate the relationships between levels of systemic inflammation, immune function and likelihood to die from the illness. The study appears in the January issue of Critical Care Medicine.

22 Jan 2013

Synthon Biopharmaceuticals announces promising results with its antibody-drug conjugate program

Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).

22 Jan 2013

Psychiatrists exposed to COI policies during residency less likely to prescribe brand antidepressants

Psychiatrists who are exposed to conflict-of-interest (COI) policies during their residency are less likely to prescribe brand-name antidepressants after graduation than those who trained in residency programs without such policies, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.

22 Jan 2013

FDA approves Ampio’s IND for Optina for treatment of diabetic macular edema

Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.

22 Jan 2013

Waters and Fera launch new international food safety training facility

A major new international food safety training facility, aimed at improving compliance with EU food import standards, is being launched today by The Food and Environment Research Agency (Fera) and analytical equipment manufacturer Waters®.

22 Jan 2013

Rainbow Coral visits genome-mapping facility in Houston

Since the new year began, Rainbow Coral Corp. has wasted no time in searching for new targets to add to its portfolio of projects for commercialization. Last week, the Company's executive leadership accepted an invitation to tour a genome-mapping facility in Houston with which RBCC could soon partner.

22 Jan 2013

Mitsubishi Tanabe Pharma in-licenses CETP inhibitor to Dezima Pharma

Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.

22 Jan 2013

Expect Advertising to launch Bolton Medical’s Relay Thoracic Stent-Graft

Bolton Medical has selected Expect Advertising for the launch of their new product, Relay Thoracic Stent-Graft. Expect Advertising will develop strategic planning, branding, ad campaign, website, tradeshow, collaterals, SEO, direct marketing, physician/patient education material, and other integrated marketing initiatives for the launch of Relay.

22 Jan 2013

INPC provides early warning of influenza outbreaks and other communicable diseases

The Centers for Disease Control has reported that influenza activity is high across most of the United States. The Indiana Network for Patient Care's ability to track data from physician offices and medical facilities across Indiana provides public health officials in the Hoosier state with early warning of outbreaks of influenza and other communicable diseases in Indiana.

22 Jan 2013

Physical activity policies: an interview with Dr Nick Cavill

Our bodies were designed to be active. The human body is not meant to spend long periods of time sitting but that’s what our modern lives have led us to do. The result has been the increase in obesity seen across the world, and up to 20 other conditions including cardiovascular disease and diabetes.

22 Jan 2013

Researchers say Germany risks eroding its moral authority unless it protects fundamental rights

A research team comprising of academics, political analysts, human rights activists, journalists and representatives of minority groups presented a study in Brussels Monday that seriously questions human rights violations in Germany, concluding that the country risks eroding its moral authority if it does not do more to protect fundamental rights within its own borders.

22 Jan 2013

Medical News

Intelligent algorithms for programming deep brain stimulation in Parkinson’s to be developed by Great Lakes NeuroTechnologies

Chronic heart failure treatment, Inspra (eplerenone), accepted for use within NHS Wales

PathCentral announces roll-out of new pathology network

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Calmangafodipir protects against side effects of cancer treatments

New special issue explores link between evolution and the body's fight against cancer

Dutasteride decreases risk of biopsy detectable prostate cancer by 22.8%

Simcere enters share transfer agreement with Devont Asset Management

Russia approves FzioMed’s Oxiplex gel for lumbar spine surgery

Suppression of immune system function can occur in influenza patients

Synthon Biopharmaceuticals announces promising results with its antibody-drug conjugate program

Psychiatrists exposed to COI policies during residency less likely to prescribe brand antidepressants

FDA approves Ampio’s IND for Optina for treatment of diabetic macular edema

Waters and Fera launch new international food safety training facility

Rainbow Coral visits genome-mapping facility in Houston

Mitsubishi Tanabe Pharma in-licenses CETP inhibitor to Dezima Pharma

Expect Advertising to launch Bolton Medical’s Relay Thoracic Stent-Graft

INPC provides early warning of influenza outbreaks and other communicable diseases

Physical activity policies: an interview with Dr Nick Cavill

Researchers say Germany risks eroding its moral authority unless it protects fundamental rights

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News